The Readout Loud Por: STAT STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come. 386 episodios disponibles Latest episodes of the podcast The Readout Loud Mostrando página 3 de 20 342: FDA cuts, zombie biotechs, and too much weight loss? 20/02/2025 341: NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers 13/02/2025 340: Crisis in CRISPR world, RFK Jr.'s promises, and a novel non-opioid pain drug 06/02/2025 339: RFK Jr.'s confirmation hearings, MASH drugs, and a controversial obesity ad 30/01/2025 338: Chinese biotechs, a WHO departure, and post-JPM thoughts 23/01/2025 337: Eli Lilly CEO on Trump, obesity drugs, and a guidance miss 15/01/2025 336: Pharma's big patent cliff, more obesity fundraising, and a failed ALS study 09/01/2025 335: A deep dive on Makary, Vertex's pain data, & 2025 predictions 19/12/2024 334: Pharma silence on RFK Jr. & parents trying to develop gene therapies for their children 12/12/2024 333: An H5N1 bird flu update and talent scarcity in the radiopharma field 05/12/2024 332: Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner? 21/11/2024 331: AbbVie’s stumble, Amgen’s tumble and more election fallout 14/11/2024 330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks 07/11/2024 329: Lilly's earnings surprise, investors mull the election, & a spooky ghost story 31/10/2024 328: Pfizer's activist troubles, gene therapy questions, RFK Jr.'s MAHA ambitions 24/10/2024 327: Biotech's next gold rush, GLP-1 shortages, and STAT Summit highlights 17/10/2024 326: Crypto for CRISPR, a new RNAi startup, & a Nobel for AI 10/10/2024 325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO 03/10/2024 From Tradeoffs: Race to the Bottom 28/09/2024 324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug 26/09/2024 « Primera ‹ Anterior 1 2 3 4 5 ... 20 Siguiente › Última » Share Facebook Twitter LinkedIn